In December 2016, the World Health Organization (WHO) published an editorial "Clarifying WHO's position on the FRAX® tool for fracture prediction" in the Bulletin of the World Health Organization stating, among other things, that the FRAX® tool to evaluate fracture risks of patients is not a 'WHO tool' and has not been developed, endorsed, evaluated or validated by WHO, notwithstanding any public statements and claims to that effect". The editorial further clarified that "according to our records, WHO has not authorized the use of the WHO name, acronym or emblem in connection with the FRAX tool, including for the tool's branding, promotion or sale." It also stated that the University of Sheffield's Metabolic Bone Disease Unit was designated as a WHO Collaborating Centre from 1991 to 2010 only, at which time such designation expired. A copy of the editorial is enclosed with this letter for your reference and is available at http://www.who.int/ bulletin/volumes/94/12/16-188532/en/.
At this time, WHO is formally asking all journals that have published more than one article containing information which contradicts or is inconsistent with the abovementioned clarifications and/or editorial to publicly correct their records concerning such misinformation.
Based on our research, we have identified that 180 journals and up to 595 articles are concerned-including Przeglad Menopauzalny and the following two articles published therein (collectively, "Correctable Articles"): 
